A specialty pharmaceutical company poised to
become the No. 1 supplier of OTC products for the diabetes population.
A detailing pharmaceutical company positioned
to capture a share of the diabetes Rx business.
A niche generic pharmaceutical manufacturer supplying
products to drug chains and wholesalers.
A contract manufacturer operating a 135,000-sq.
ft. state-of-the-art pharmaceutical plant with facilities for Research
& Development, manufacturing and distribution.
A sterile manufacturer with an ophthalmic,
otic and inhalation product facility meeting FDA standards.
An R&D innovator with FDA approval of 23 products
and an active pipeline.
A niche marketing specialist projecting
double digit growth through 2002.
An undervalued publicly traded company with a record
of strong earnings and a bright future.
A seasoned industry player and a groundfloor
investment opportunity.
